Whole-Body 18F-Fluorocholine (FCH) PET/CT and MRI of the Spine for Monitoring Patients With Castration-Resistant Prostate Cancer Metastatic to Bone-Reference-Cited by-同舟云学术

Whole-Body 18F-Fluorocholine (FCH) PET/CT and MRI of the Spine for Monitoring Patients With Castration-Resistant Prostate Cancer Metastatic to Bone

Published:2014-11 Issue:11 Volume:39 Page:951-959
ISSN:0363-9762
Container-title:Clinical Nuclear Medicine
language:en
Short-container-title:

Author:

Balogova Sona,Zakoun Joseph Ben,Michaud Laure,Khalil Antoine,Tassart Marc,Esteso Adoracion,Kerrou Khaldoun,Huchet Virginie,Carette Marie-France,Lotz Jean-Pierre,Talbot Jean-Noël

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Reference31 articles.

1. Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group.;Scher;J Clin Oncol,2008

2. Castration-resistant prostate cancer: current and emerging treatment strategies.;Di Lorenzo;Drugs,2010

3. Prostate-specific antigen changes as surrogate for overall survival in men with metastatic castration-resistant prostate cancer treated with second-line chemotherapy.;Halabi;J Clin Oncol,2013

4. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).;Eisenhauer;Eur J Cancer,2009

5. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-Fluoride PET, and 18F-Fluoride PETCT.;Even-Sapir;J Nucl Med,2006

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 10.31348/2020/5;Czech and Slovak Ophthalmology;2020-09-01

2. 68Ga-PSMA-11 PET/CT in restaging castration-resistant nonmetastatic prostate cancer: detection rate, impact on patients’ disease management and adequacy of impact;Scientific Reports;2020-02-07

3. Radiothérapie interne vectorisée par 177Lu-PSMA-617 de l’adénocarcinome prostatique métastatique résistant à la castration : à propos d’un cas et revue de la littérature;Médecine Nucléaire;2019-05

4. Imagerie du cancer de la prostate oligométastatique, le point de vue du médecin nucléaire;Médecine Nucléaire;2019-03

5. Editorial Comment: Advances in MRI and PET of the prostate: concurrence or complementarity?;European Radiology;2018-06-01